Lapix Therapeutics
Lapix Therapeutics is a startup headquartered in Cambridge, United States, founded in 2019. It has raised at least $5.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Lapix Therapeutics has raised at least $5.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Lapix Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- 2Pi
- Acceleron Fusion
- actnano
- AIScientists
- Apeiron Labs
- Aptamino
- Arches Medical Independents
- Aviceda Therapeutics
- Axoft
- Blitzy
- Caldera Therapeutics
Related
- Innovation profile of Cambridge
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Lapix Therapeutics do?
Lapix Therapeutics is classed in technology in its filings with the US Securities and Exchange Commission.
How much has Lapix Therapeutics raised?
At least $5.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Lapix Therapeutics based?
Lapix Therapeutics is headquartered in Cambridge, United States.
When was Lapix Therapeutics founded?
Lapix Therapeutics was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.